Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population

BACKGROUND: Despite being the world’s most widely used system for staging and therapeutic guidance in hepatocellular carcinoma (HCC) treatment, the Barcelona clinic liver cancer (BCLC) system has limitations, especially regarding intermediate-grade (BCLC-B) tumors. The recently proposed Hong Kong li...

Descripción completa

Detalles Bibliográficos
Autores principales: de Freitas, Laura Bainy Rodrigues, Longo, Larisse, Santos, Deivid, Grivicich, Ivana, Álvares-da-Silva, Mário Reis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783400/
https://www.ncbi.nlm.nih.gov/pubmed/31602288
http://dx.doi.org/10.4254/wjh.v11.i9.678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783400/
https://www.ncbi.nlm.nih.gov/pubmed/31602288
http://dx.doi.org/10.4254/wjh.v11.i9.678

Ejemplares similares